Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kissei Pharmaceutical CoKSPHF -4.45%79 Pretax Margin % is 13.26% as of Mar. 2026, which is 20% below its 10-year median of 16.58. GuruFocus rates KSPHF with a GF Score™ of 79/100 and a GF Value™ of $31.34. The stock has 1 warning sign investors should review. Among 961 Drug Manufacturers companies, Kissei Pharmaceutical Co ranks better than 75.86% on this metric.
Kissei Pharmaceutical Co (OTCPK:KSPHF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Kissei Pharmaceutical Co Pretax Margin % Related Terms
Kissei Pharmaceutical Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kissei Pharmaceutical Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Kissei Pharmaceutical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kissei Pharmaceutical Co (KSPHF) has a Pretax Margin % of 13.26% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kissei Pharmaceutical Co and its competitors. This is 20% below median its historical median of 16.58. Over the past decade, Kissei Pharmaceutical Co's Pretax Margin % has ranged from 7.32 to 25.25. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #232 out of 961 companies in the Drug Manufacturers industry, placing it in the top 24.1%.
Is Kissei Pharmaceutical Co's Pretax Margin % too high?
Kissei Pharmaceutical Co's current Pretax Margin % of 13.26% is 20% below median its 10-year median of 16.58. Over the past 10 years, this metric has ranged from a low of 7.32 to a high of 25.25. The Drug Manufacturers industry median Pretax Margin % is 7.06. Kissei Pharmaceutical Co's value of 13.26% is 87.8% above this industry median. Based on the distribution chart, Kissei Pharmaceutical Co ranks #232 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #232 out of 961 companies for Pretax Margin %. This places Kissei Pharmaceutical Co in the top 24% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.06. Kissei Pharmaceutical Co's value of 13.26% is 87.8% above this benchmark. Historically, Kissei Pharmaceutical Co's own Pretax Margin % has ranged from 7.32 to 25.25 over the past decade. While the company's 10-year median is 16.58 vs. the industry median of 7.06, Kissei Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.06, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kissei Pharmaceutical Co's current Pretax Margin % of 13.26% is 87.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kissei Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kissei Pharmaceutical Co's current Pretax Margin % is 13.26%, which is 20% below median its own 10-year median of 16.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Kissei Pharmaceutical Co (KSPHF) has a current Pretax Margin % of 13.26%. The stock's GF Value™ is $31.34, compared to a current price of $25.77 — trading 17.8% below its estimated fair value. The current Pretax Margin % is 13.26%, which is 20% below median its 10-year median of 16.58 and 87.8% above the Drug Manufacturers industry median of 7.06. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Kissei Pharmaceutical Co (KSPHF), the current Pretax Margin % is 13.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kissei Pharmaceutical Co (KSPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued.
The current stock price of $25.77 is trading 17.8% below its estimated GF Value™ of $31.34.
Key valuation signals for KSPHF:
Pretax Margin %: 13.26% (20% below median its 10-year median of 16.58)
GF Value™: $31.34 vs. price of $25.77 (17.8% below fair value)
Industry Position: 87.8% above the Drug Manufacturers median (#232 of 961)
No single metric tells the full story. See the KSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score
Get the complete analysis for KSPHF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KSPHF has been successfully added to your 
